Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Capital Reinvestment Ratio
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Capital Reinvestment Ratio of 1.07x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.48 Million) in capital expenditures (CN¥16.52 Million). See 002099 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Hisoar Pharmaceutical Co Ltd Capital Reinvestment Ratio (2004–2024)
This chart tracks Zhejiang Hisoar Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 21 annual periods. Check Zhejiang Hisoar Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Hisoar Pharmaceutical Co Ltd (2004–2024)
Year-by-year Capital Reinvestment Ratio for Zhejiang Hisoar Pharmaceutical Co Ltd from 2004 to 2024. For live market cap and broader valuation context, see 002099 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.70x | CN¥174.83 Million | CN¥122.11 Million | ▲ +9.7% |
| 2023 | 0.64x | CN¥240.54 Million | CN¥153.08 Million | ▼ -58.8% |
| 2022 | 1.55x | CN¥116.09 Million | CN¥179.42 Million | ▼ -31.1% |
| 2021 | 2.24x | CN¥102.36 Million | CN¥229.56 Million | ▲ +1514.0% |
| 2020 | 0.14x | CN¥533.87 Million | CN¥74.18 Million | ▼ -47.0% |
| 2019 | 0.26x | CN¥612.40 Million | CN¥160.64 Million | ▼ -18.8% |
| 2018 | 0.32x | CN¥791.45 Million | CN¥255.78 Million | ▼ -77.7% |
| 2017 | 1.45x | CN¥102.68 Million | CN¥148.99 Million | ▲ +634.7% |
| 2016 | 0.20x | CN¥629.42 Million | CN¥124.31 Million | ▼ -69.2% |
| 2015 | 0.64x | CN¥462.16 Million | CN¥296.36 Million | ▼ -27.3% |
| 2014 | 0.88x | CN¥191.56 Million | CN¥169.06 Million | ▼ -80.9% |
| 2013 | 4.63x | CN¥60.85 Million | CN¥281.79 Million | ▲ +96.1% |
| 2012 | 2.36x | CN¥180.73 Million | CN¥426.79 Million | ▲ +0.5% |
| 2011 | 2.35x | CN¥92.62 Million | CN¥217.52 Million | ▲ +190.0% |
| 2010 | 0.81x | CN¥180.88 Million | CN¥146.51 Million | ▲ +48.7% |
| 2009 | 0.54x | CN¥98.38 Million | CN¥53.60 Million | ▼ -81.6% |
| 2008 | 2.95x | CN¥30.61 Million | CN¥90.40 Million | ▲ +34.1% |
| 2007 | 2.20x | CN¥51.14 Million | CN¥112.61 Million | ▲ +32.8% |
| 2006 | 1.66x | CN¥61.88 Million | CN¥102.59 Million | ▼ -18.9% |
| 2005 | 2.04x | CN¥36.07 Million | CN¥73.74 Million | ▲ +103.6% |
| 2004 | 1.00x | CN¥42.36 Million | CN¥42.54 Million | — |